one specifically inhibiting the lymphocytotoxic activity of anti-hla-b8 , b5 , and dr3 reference typing sera , and the other specifically inhibiting proliferative responses in mlc of the recipient 's lymphocytes and of third party cells sharing b14 , dr1 , dqw1 with the patient against stimulator cells carrying b8 , dr3 antigens .
C0301896
lymphocytotoxic
C0003320
antigens